News

The exclusive license grants GCAT the right, through its Chinese joint venture with Tianjing Institute of Pharmaceutical Research, to clinically develop and commercialize elvucitabine in mainland China, Hong

This facility is likely to provide on-site chemistry resources for Pfizer along with a resource for other developing companies in the vicinity. Tony Wood, vice president of world-wide

The prospective, observational study involved 321 patients with acute STEMI, without cardiogenic shock, who received 357 Genous stents. The rate of major adverse cardiac events (MACE) was 8.1%

UPA is a new emergency contraceptive developed by HRA Pharma specifically for emergency contraceptive use, that is approved and marketed by HRA Pharma in Europe as ellaOne since

Pyng Medical claims that it is the first company to offer an adult intraosseous infusion device, and continues to innovate in resuscitation, with simple-to-use products including FAST1 intraosseous

The clinical trial is being conducted in approximately 25 sites across the US and is expected to enroll 440 adult patients with acute uncomplicated influenza. It is also

To support its R&D program, LecTec has established relationships with bio-medical companies based in China, Japan, Thailand and the US, to assist the company in developing its antimicrobial

Bioflor (Saccharomyces boulardii) is a probiotic antidiarrheal product mainly used in the prevention and treatment of diarrhea, a common gastroentrologic disorder found in adults and children. Under the

SDI was selected for a third consecutive time as the key monoclonal antibody provider. The National Cancer Institute’s CPTC will extensively characterize these reagents, consistent with their mission